ISSN:
1432-1238
Keywords:
Sepsis
;
Staph. aureus
;
ARDS
;
Corticosteroid
;
Aerosol
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Objective To assess effects of nebulized corticosteroid on lung function in sepsis. Design Randomized, placebo-controlled, blinded study in septic pigs. Setting A trauma research laboratory Materials 16 juvenile pigs, one excluded due to pulmonary hypertension at baseline. Interventions Mechanical ventilation and continuous light anesthesia. Brief infusion of liveStaph. aureus (4×1010cfu) followed by nebulization of beclomethasone sone dipropionate (BDP) 50μg/kg (n=8) or placebo (n=7) 30 and 360 min after start of septic challenge. Measurements and results Vascular pressures, cardiac output, lung mechanics, gas exchange and oxygen transport variables were measured at regular intervals. An identical transient rise in mean pulmonary artery pressure was seen in both groups (mean±SD: 48±4 mmHg), followed by a gradual increase in pulmonary vascular resistance, reaching maximum at 4h but significantly reduced by BDP compared to placebo (p〈0.01, ANOVA). Mean systemic arterial pressure, arterial oxygen tension and lung compliance did not change significantly in the BDP group, but they all declined in the placebo-group (p〈0.01 compared to baseline,p〈0.05–0.01 between the groups). Oxygen delivery decreased significantly in the placebo group at 12h (p〈0.05). Oxygen extraction increased in both groups (p〈0.01 compared to baseline), being significantly higher in the placebo group at 12h (p〈0.05). Conclusion Nebulized corticosteroid protects pulmonary function in sepsis, indicating a therapeutic role in the treatment of septic ARDS.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF01720531
Permalink
